- Home
- NVAX vs KAR Comparison
NVAX vs KAR Comparison
Compare NVAX & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- KAR
- Stock Information
- Founded
- NVAX 1987
- KAR 2006
- Country
- NVAX United States
- KAR United States
- Employees
- NVAX N/A
- KAR N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- KAR Retail-Auto Dealers and Gas Stations
- Sector
- NVAX Health Care
- KAR Consumer Discretionary
- Exchange
- NVAX Nasdaq
- KAR Nasdaq
- Market Cap
- NVAX 2.0B
- KAR 2.2B
- IPO Year
- NVAX 1995
- KAR 2009
- Fundamental
- Price
- NVAX $8.57
- KAR $20.18
- Analyst Decision
- NVAX Buy
- KAR Buy
- Analyst Count
- NVAX 6
- KAR 4
- Target Price
- NVAX $17.83
- KAR $22.00
- AVG Volume (30 Days)
- NVAX 3.3M
- KAR 822.8K
- Earning Date
- NVAX 02-26-2025
- KAR 02-18-2025
- Dividend Yield
- NVAX N/A
- KAR N/A
- EPS Growth
- NVAX N/A
- KAR N/A
- EPS
- NVAX N/A
- KAR 0.19
- Revenue
- NVAX $885,193,000.00
- KAR $1,687,800,000.00
- Revenue This Year
- NVAX N/A
- KAR $5.10
- Revenue Next Year
- NVAX N/A
- KAR $3.82
- P/E Ratio
- NVAX N/A
- KAR $108.03
- Revenue Growth
- NVAX N/A
- KAR 3.76
- 52 Week Low
- NVAX $3.53
- KAR $12.86
- 52 Week High
- NVAX $23.86
- KAR $20.85
- Technical
- Relative Strength Index (RSI)
- NVAX 48.28
- KAR 53.66
- Support Level
- NVAX $7.62
- KAR $19.73
- Resistance Level
- NVAX $8.67
- KAR $20.56
- Average True Range (ATR)
- NVAX 0.46
- KAR 0.47
- MACD
- NVAX -0.03
- KAR -0.14
- Stochastic Oscillator
- NVAX 44.60
- KAR 42.45
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.